Musings from The Power List: Dajun Yang - Poll - MDSpire

Musings from The Power List: Dajun Yang

The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics

September 15, 2026
5 min

The Medicine Maker

Share

Original Source(s)

The Medicine Maker

Musings from The Power List: Dajun Yang

September 15, 2026

Related Content

Journal Of Medical Internet Research

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

by Marek Atter, Alistair Bullen, Kathrin Cresswell, Peter S Hall
September 11, 2026

Journal Of Medical Internet Research

The Effectiveness of Digital Intervention on Psychological Resilience in Postoperative Breast Cancer Patients During Chemotherapy Intervals: Quasi-Experimental Study

by Xin He, Qianyu Zhang, Liping Wang, Qunying Fang, Chen Chen, Shujin Wang, Erlong Sun, Jinghan Yang, Weichao Liu
September 11, 2026

World Journal Of Urology

Six-factor-based stratification system for enfortumab vedotin monotherapy in pre-treated patients with metastatic or locally advanced urothelial carcinoma